Macquarie Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.16M Sell
84,182
-41,237
-33% -$3.68M 0.04% 289
2025
Q4
$9.89M Buy
125,419
+14,724
+13% +$1.15M 0.04% 292
2025
Q3
$8.84M Sell
110,695
-15,968
-13% -$1.36M 0.01% 836
2025
Q2
$11.5M Sell
126,663
-23,445
-16% -$2.14M 0.01% 786
2025
Q1
$14M Sell
150,108
-502,824
-77% -$45M 0.02% 744
2024
Q4
$9.04M Buy
652,932
+506,698
+346% +$48.4M 0.01% 824
2024
Q3
$15.2M Buy
146,234
+71,124
+95% +$7.25M 0.02% 749
2024
Q2
$7.29M Sell
75,110
-1,413
-2% -$130K 0.01% 881
2024
Q1
$6.89M Sell
76,523
-6,102
-7% -$517K 0.01% 895
2023
Q4
$6.59M Buy
82,625
+12,555
+18% +$944K 0.01% 909
2023
Q3
$4.98M Buy
70,070
+5,597
+9% +$418K 0.01% 925
2023
Q2
$4.97M Buy
64,473
+4,412
+7% +$342K 0.01% 932
2023
Q1
$4.37M Buy
60,061
+31,190
+108% +$2.32M 0.01% 958
2022
Q4
$2.27M Sell
28,871
-17,406
-38% -$1.3M ﹤0.01% 1176
2022
Q3
$3.25M Sell
46,277
-124,220
-73% -$9.74M ﹤0.01% 1092
2022
Q2
$13.7M Sell
170,497
-23,218
-12% -$1.82M 0.02% 795
2022
Q1
$14.7K Sell
193,715
-32,552
-14% -$2.58M 0.01% 842
2021
Q4
$19.3M Buy
226,267
+77,153
+52% +$6.02M 0.02% 758
2021
Q3
$11.3M Buy
149,114
+5,312
+4% +$422K 0.01% 891
2021
Q2
$11.7M Buy
143,802
+26,679
+23% +$2.18M 0.01% 898
2021
Q1
$9.23M Buy
117,123
+53,736
+85% +$4.21M 0.01% 736
2020
Q4
$5.42M Buy
63,387
+7,722
+14% +$639K 0.01% 864
2020
Q3
$4.29M Buy
55,665
+3,861
+7% +$294K 0.01% 868
2020
Q2
$3.79M Sell
51,804
-15,036
-22% -$1.07M 0.01% 854
2020
Q1
$4.44M Sell
66,840
-389
-0.6% -$27.4K 0.01% 740
2019
Q4
$4.63M Buy
67,229
+30,369
+82% +$2.07M 0.01% 826
2019
Q3
$2.71M Hold
36,860
﹤0.01% 938
2019
Q2
$2.64M Buy
36,860
+3,943
+12% +$280K ﹤0.01% 945
2019
Q1
$2.26M Sell
32,917
-491
-1% -$31.7K ﹤0.01% 964
2018
Q4
$1.99M Sell
33,408
-713
-2% -$44.6K ﹤0.01% 968
2018
Q3
$2.28M Sell
34,121
-448
-1% -$29.8K ﹤0.01% 982
2018
Q2
$2.24M Buy
34,569
+23,169
+203% +$1.52M ﹤0.01% 965
2018
Q1
$818K Sell
11,400
-400
-3% -$28.8K ﹤0.01% 1237
2017
Q4
$1M Sell
11,800
-2,200
-16% -$161K ﹤0.01% 1243
2017
Q3
$1.02M Buy
14,000
+5,700
+69% +$411K ﹤0.01% 1206
2017
Q2
$616K Sell
8,300
-1,140
-12% -$84.6K ﹤0.01% 1271
2017
Q1
$690K Sell
9,440
-15,720
-62% -$1.1M ﹤0.01% 1261
2016
Q4
$1.65M Sell
25,160
-5,720
-19% -$392K ﹤0.01% 1025
2016
Q3
$2.29M Sell
30,880
-20,440
-40% -$1.51M ﹤0.01% 920
2016
Q2
$3.76M Buy
51,320
+32,520
+173% +$2.32M ﹤0.01% 971
2016
Q1
$1.33M Sell
18,800
-6,650
-26% -$442K ﹤0.01% 1056
2015
Q4
$1.7M Sell
25,450
-46,620
-65% -$3.1M ﹤0.01% 974
2015
Q3
$4.57M Sell
72,070
-184,357
-72% -$12M 0.01% 741
2015
Q2
$16.8M Sell
256,427
-1,770
-0.7% -$120K 0.03% 402
2015
Q1
$17.9M Sell
258,197
-310
-0.1% -$21.4K 0.04% 402
2014
Q4
$17.9M Sell
258,507
-3,910
-1% -$264K 0.04% 402
2014
Q3
$17.1M Buy
262,417
+6,687
+3% +$441K 0.04% 404
2014
Q2
$17.4M Buy
255,730
+92,815
+57% +$6.22M 0.04% 388
2014
Q1
$10.6M Buy
162,915
+10,218
+7% +$644K 0.02% 487
2013
Q4
$9.96M Sell
152,697
-88,403
-37% -$5.66M 0.02% 474
2013
Q3
$14.3M Buy
241,100
+51,169
+27% +$3.03M 0.03% 382
2013
Q2
$10.9M Buy
+189,931
New +$11.3M 0.02% 416

Other funds holding CL

Macquarie Group's CL Position: Q1 2026 in Review

Macquarie Group reduced its Colgate-Palmolive (CL) stake by 33% in Q1 2026, selling an estimated $3.68M and leaving 84,182 shares worth $7.16M. The position accounts for 0.04% of the portfolio, ranked #289.

Macquarie Group first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.3M in Q4 2021. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Macquarie Group held 84,182 shares of Colgate-Palmolive worth $7.16M as of Q1 2026.
  • Macquarie Group sold 41,237 Colgate-Palmolive shares in Q1 2026, an estimated $3.68M.
  • Colgate-Palmolive made up 0.04% of Macquarie Group's portfolio in Q1 2026, its #289 holding.
  • Macquarie Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Macquarie Group's Colgate-Palmolive position peaked at $19.3M in Q4 2021.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.